Direct Gene Transfer for the Understanding and Treatment of Human Disease
dc.contributor.author | Plautz, Gregory E. | en_US |
dc.contributor.author | Nabel, Elizabeth G. | en_US |
dc.contributor.author | Fox, Bernard A. | en_US |
dc.contributor.author | Yang, Zhi-Yong | en_US |
dc.contributor.author | Jaffe, Michele L. | en_US |
dc.contributor.author | Gordon, David | en_US |
dc.contributor.author | Chang, Alfred | en_US |
dc.contributor.author | Nabel, Gary J. | en_US |
dc.date.accessioned | 2010-06-01T22:47:54Z | |
dc.date.available | 2010-06-01T22:47:54Z | |
dc.date.issued | 1994-05 | en_US |
dc.identifier.citation | PLAUTZ, GREGORY E.; NABEL, ELIZABETH G.; FOX, BERNARD; YANG, ZHI-YONG; JAFFE, MICHELE; GORDON, DAVID; CHANG, ALFRED; NABEL, GARY J. (1994). "Direct Gene Transfer for the Understanding and Treatment of Human Disease." Annals of the New York Academy of Sciences 716(1 Gene Therapy for Neoplastic Diseases ): 144-153. <http://hdl.handle.net/2027.42/75762> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75762 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8024191&dopt=citation | en_US |
dc.format.extent | 681739 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1994 The New York Academy of Sciences | en_US |
dc.title | Direct Gene Transfer for the Understanding and Treatment of Human Disease | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pediatrics and Communicable Diseases, University of Michigan Medical Center, Ann Arbor, Michigan 48109–0684 | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109–0684 | en_US |
dc.contributor.affiliationum | Department of Biologial Chemistry, University of Michigan Medical Center, Ann Arbor, Michigan 48109–0684 | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109–0684 | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 48109–0684 | en_US |
dc.contributor.affiliationum | Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor, Michigan 48109–0684 | en_US |
dc.identifier.pmid | 8024191 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75762/1/j.1749-6632.1994.tb21709.x.pdf | |
dc.identifier.doi | 10.1111/j.1749-6632.1994.tb21709.x | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Price, J., D. Turner & C. Cepko. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84: 156 – 160. | en_US |
dc.identifier.citedreference | Nabel, E. G., G. Plautz & G. J. Nabel. 1990. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249: 1285 – 1288. | en_US |
dc.identifier.citedreference | Culver, K. W., Z. Ram, S. Wallbridge, H. Ishii, E. H. Oldfield & R. M. Blaese. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550 – 1552. | en_US |
dc.identifier.citedreference | Rosenfeld, M. A., W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L. E. Stier, P. K. Paakko, P. Gilardi, L. D. Stratford-Perricaudet, M. Perricaudet et al. 1991. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252: 431 – 434. | en_US |
dc.identifier.citedreference | Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet et al. 1992. In vivo transfer of the human cystic fibrosis trans-membrane conductance regulator gene to the airway epithelium. Cell 68: 143 – 155. | en_US |
dc.identifier.citedreference | Jaffe, H. A., C. Danel, G. Longenecker, M. Metzger, Y. Setoguchi, M. A. Rosenfeld, T. W. Gant, S. S. Thorgeirsson, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. P. Lecocq & R. G. Crystal. 1992. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1: 372 – 378. | en_US |
dc.identifier.citedreference | Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein & L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 [ published erratum appears in EMBO J. 1992. Mar; 11(3): 1228 ]. EMBO J. 10: 3941 – 3950. | en_US |
dc.identifier.citedreference | Palella, T. D., L. J. Silverman, C. T. Schroll, F. L. Homa, M. Levine & W. N. Kelley. 1988. Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransrase gene transfer into neuronal cells. Mol. Cell. Biol. 8: 457 – 460. | en_US |
dc.identifier.citedreference | Chiocca, E. A., B. B. Choi, W. Z. Cai, N. A. De Luce, P. A. Schaffer, M. De Figlia, X. O. Breakfield & R. L. Martuza. 1990. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol. 2: 739 – 746. | en_US |
dc.identifier.citedreference | Breakefield, X. O. & N. A. De Luca. 1991. Herpes simplex virus for gene delivery to neurons. New Biol. 3: 203 – 218. | en_US |
dc.identifier.citedreference | Wolff, J. A., R. W. Malone, P. Williams, G. Chong, G. Ascadi, A. Jani & P. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465 – 1468. | en_US |
dc.identifier.citedreference | Lin, H., M. S. Parmacek, G. Morle, S. Bolling & J. M. Leiden. 1990. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82: 2217 – 2221. | en_US |
dc.identifier.citedreference | Acsadi, G., S. S. Jiao, A. Jani, D. Duke, P. Williams, W. Chong & J. A. Wolff. 1991. Direct gene transfer and expression into rat heart in vivo. New Biol. 3: 71 – 81. | en_US |
dc.identifier.citedreference | Vile, R. G. & I. R. Hart. 1993 In Vitro and in vivo Targeting of gene expression to melanoma cells. Cancer Res. 53: 962 – 967. | en_US |
dc.identifier.citedreference | Brigham, K. L., B. Meyrick, B. Christman, M. Magnuson, G. King & L. C. Berry. 1989. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 298: 278 – 281. | en_US |
dc.identifier.citedreference | Holt, C. I., N. Garlick & E. Cornel. 1990. Lipofection of cDNAs in the embryonic vertebrate central nervous system. Neuron 4: 203 – 214. | en_US |
dc.identifier.citedreference | Plautz, G. E., Z. Y. Yang, B. Wu, X. Gao, L. Huang & G. J. Nabel. 1993. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA 90: 4645 – 4649. | en_US |
dc.identifier.citedreference | Nabel, E. G., Z. Yang, G. Plautz, R. Forough, X. Zhan, C. C. Haudenschild, T. Maciag & G. J. Nabel. 1993. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362: 844 – 846. | en_US |
dc.identifier.citedreference | Nabel, E. G., Z. Yang, S. Liptay, H. San, D. Gordon, C. C. Haudenschild & G. J. Nabel. 1993. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J. Clin. Invest. 91: 1822 – 1829. | en_US |
dc.identifier.citedreference | Felgner, P. L. & G. M. Ringold. 1989. Cationic liposome-mediated transfection. Nature 337: 387 – 388. | en_US |
dc.identifier.citedreference | Felgner, P. L., M. Holm & H. Chan. 1989. Cationic liposome mediated transfection. Proc. West. Pharmacol. Soc. 32: 115 – 121. | en_US |
dc.identifier.citedreference | Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold & M. Danielsen. 1987. Lipofection: A highly efficient lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84: 7413 – 7417. | en_US |
dc.identifier.citedreference | Nabel, E. G., G. Plautz & G. J. Nabel. 1992. Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. Proc. Natl. Acad. Sci. USA 89: 5157 – 5161. | en_US |
dc.identifier.citedreference | Lim, C. S., G. D. Chapman, R. S. Gammon, J. B. Muhlestein, R. P. Bauman, R. S. Stack & J. L. Swain. 1991. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation 83: 2007 – 2011. | en_US |
dc.identifier.citedreference | Gao, X. & L. Huang. 1991. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179: 280 – 285. | en_US |
dc.identifier.citedreference | Stewart, M. J., G. E. Plautz, L. Del Buono, Z. Y. Yang, L. Xu, X. Gao, L. Huang, E. G. Nabel & G. J. Nabel. 1992. Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice. Hum. Gene Ther. 3: 267 – 275. | en_US |
dc.identifier.citedreference | Nabel, E. G., D. Gordon, Z.-Y. Xang, L. Xu, H. San, G. E. Plautz, X. Gao, L. Huang & G. J. Nabel. 1992. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization. Hum. Gene Ther. 3: 649 – 656. | en_US |
dc.identifier.citedreference | Fearon, E. R., D. M. Pardoll, T. Itaya, P. Golumbek, H. I. Levitsky, J. W. Simons, H. Karasuyama, B. Vogelstein & P. Frost. 1990. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397 – 403. | en_US |
dc.identifier.citedreference | Gansbacher, B., K. Zier, B. Daniels, K. Cronin, R. Bannerji & E. Gilboa. 1990. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172: 1217 – 1224. | en_US |
dc.identifier.citedreference | Tepper, R. I., P. K. Pattengale & P. Leder. 1989. Murine interleukin-4 displays potent antitumor activity in vivo. Cell 57: 503 – 512. | en_US |
dc.identifier.citedreference | Li, W., T. Diamantstein & T. Blankenstein. 1990. Lack of tumorienicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4. Mol. Immunol. 27: 1331 – 1337. | en_US |
dc.identifier.citedreference | Golumbek, P. T., A. J. Lazenby, H. I. Levitsky, L. M. Jaffee, H. Karasuyama, M. Baker & D. M. Pardoll. 1991. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713 – 716. | en_US |
dc.identifier.citedreference | Gansbacher, B., R. Bannerji, B. Daniels, K. Zier, K. Cronin & E. Gilboa. 1990. Retroviral vector-mediated Γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50: 7820 – 7825. | en_US |
dc.identifier.citedreference | Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A. Ledbetter, P. McGowan & P. S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecule CD28 and CTLA-4. Cell 71: 1093 – 1102. | en_US |
dc.identifier.citedreference | Townsend, S. & J. P. Allison. 1993. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259: 368 – 370. | en_US |
dc.identifier.citedreference | Blankenstein, Th., Z. Qin, K. Überla, W. MÜller, H. Rosen, H.-D. Volk & T. Diamanstein. 1991. Tumor suppression after tumor cell-targeted tumor necrosis factor a gene transfer. J. Exp. Med. 173: 1047 – 1052. | en_US |
dc.identifier.citedreference | Teng, M. N., B. H. Park, H. K. Koeppen, K. J. Tracey, B. M. Fendly & H. Schreiber. 1991. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. USA 88: 3535 – 3539. | en_US |
dc.identifier.citedreference | Asher, A. L., J. J. Mule, A. Kasid, N. P. Restifo, J. C. Salo, C. M. Reichert, G. Jaffe, B. Fendly, M. Kriegler & S. A. Rosenberg. 1991. Murine tumor cells transduced with the gene for tumor necrosis factor-Α. J. Immunol. 146: 3227 – 3234. | en_US |
dc.identifier.citedreference | Parham, P., C. E. Lomen, D. A. Lawlor, J. P. Ways, N. Holmes, H. L. Coppin, R. D. Salter, A. M. Wan & P. D. Ennis. 1988. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc. Natl. Acad. Sci. USA 85: 4005 – 4009. | en_US |
dc.identifier.citedreference | Skinner, M. A. & J. Marbrook. 1976. An estimation of the frequency of precursor cells which generate cytotoxic lymhocytes. J. Exp. Med. 143: 1562 – 1567. | en_US |
dc.identifier.citedreference | Lindahl, K. E. & D. B. Wilson. 1977. Histocomatibility antigen-activated cytotoxic T lymhocytes I Estimates of the absolute frequency of killer cells generated in vitro. J. Exp. Med. 145: 500 – 522. | en_US |
dc.identifier.citedreference | Wahl, W. L., G. E. Plautz, B. A. Fox, G. J. Nabel, S. Shu & A. E. Chang. 1992. Generation of therapeutic lymphocytes after in vivo transfection of tumor with a gene encoding allogeneic class I MHC antigen. Surg. Forum 63: 476 – 478. | en_US |
dc.identifier.citedreference | Nabel, G. J., A. Chang, E. G. Nabel, G. Plautz, B. A. Fox, L. Huang & S. Shu. 1992. Clinical protocol. Immunotherapy of malignancy by in vivo gene transfer into tumors. Hum. Gene Ther. 3: 399 – 410. | en_US |
dc.identifier.citedreference | Nabel, G. J., E. G. Nabel, Z. Yang, B. Fox, G. Plautz, X. Gao, L. Huang, S. Shu, D. Gordon & A. E. Chang. 1993. Direct gene transfer with DNA liposome complexes in humans: Expression, lack of toxicity and therapeutic potential in melanoma. Proc. Natl. Acad. Sci. USA 90: 10759 – 10763. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.